Connection

Miguel Abboud to Infant

Back to Details
This is a "connection" page, showing publications Miguel Abboud has written about Infant.
Miguel Abboud
Connection Strength
1.035
Infant
  1. Emergence of gram-negative organisms as the cause of infections in patients with sickle cell disease. Pediatr Blood Cancer. 2021 01; 68(1):e28784.
    View in: PubMed
    Score: 0.111
  2. Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon. J Glob Oncol. 2019 04; 5:1-8.
    View in: PubMed
    Score: 0.099
  3. Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia. Curr Res Transl Med. 2017 09; 65(3):115-119.
    View in: PubMed
    Score: 0.090
  4. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon. Am J Hematol. 2012 Jul; 87(7):678-83.
    View in: PubMed
    Score: 0.062
  5. Iron deficiency in young Lebanese children: association with elevated blood lead levels. J Pediatr Hematol Oncol. 2008 May; 30(5):382-6.
    View in: PubMed
    Score: 0.047
  6. Prevention and management of strokes in patients with sickle cell disease. Curr Hematol Rep. 2006 Mar; 5(1):15-22.
    View in: PubMed
    Score: 0.040
  7. Clinical presentation and treatment outcome of children with Burkitt lymphoma in Lebanon: a single institution's experience. J Pediatr Hematol Oncol. 2004 Nov; 26(11):749-53.
    View in: PubMed
    Score: 0.037
  8. Diagnosis and Treatment of a Patient With Severe Combined Immunodeficiency Due to a Novel Homozygous Mutation in the IL-7Ra Chain. Front Immunol. 2022; 13:867837.
    View in: PubMed
    Score: 0.031
  9. Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider. Pediatr Blood Cancer. 2021 11; 68(11):e29210.
    View in: PubMed
    Score: 0.029
  10. Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24?months. Pediatr Blood Cancer. 2021 05; 68(5):e28977.
    View in: PubMed
    Score: 0.028
  11. Epidemiology and clinical characteristics of viral infections in hospitalized children and adolescents with cancer in Lebanon. PLoS One. 2020; 15(9):e0239258.
    View in: PubMed
    Score: 0.028
  12. Isolated Central Nervous System Relapse Following Treatment Reduction in Low-risk Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon. J Pediatr Hematol Oncol. 2020 08; 42(6):e428-e433.
    View in: PubMed
    Score: 0.027
  13. Establishment of a formal program for retinoblastoma: Feasibility of clinical coordination across borders and impact on outcome. Pediatr Blood Cancer. 2019 11; 66(11):e27959.
    View in: PubMed
    Score: 0.026
  14. The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2. Haematologica. 2018 12; 103(12):2008-2015.
    View in: PubMed
    Score: 0.024
  15. Routine surveillance imaging after end of therapy for pediatric extracranial tumors: A retrospective analysis. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.022
  16. Pediatric cancer pathology review from a single institution: Neuropathology expert opinion is essential for accurate diagnosis of pediatric brain tumors. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.022
  17. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management. Pediatr Blood Cancer. 2017 Dec; 64(12).
    View in: PubMed
    Score: 0.022
  18. Trends in hematopoietic stem cell transplant activity in Lebanon. Hematol Oncol Stem Cell Ther. 2017 Dec; 10(4):315-320.
    View in: PubMed
    Score: 0.022
  19. First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group. Bone Marrow Transplant. 2017 Jan; 52(1):120-125.
    View in: PubMed
    Score: 0.021
  20. Effect of Malnutrition at Diagnosis on Clinical Outcomes of Children With Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2016 Mar; 38(2):107-10.
    View in: PubMed
    Score: 0.020
  21. Wilms tumor: Successes and challenges in management outside of cooperative clinical trials. Hematol Oncol Stem Cell Ther. 2016 Mar; 9(1):20-5.
    View in: PubMed
    Score: 0.020
  22. Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis. Genome Med. 2015 Dec 18; 7:130.
    View in: PubMed
    Score: 0.020
  23. Approach to Non-Neutropenic Fever in Pediatric Oncology Patients-A Single Institution Study. Pediatr Blood Cancer. 2015 Dec; 62(12):2167-71.
    View in: PubMed
    Score: 0.019
  24. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2014 Aug; 24(8):387-96.
    View in: PubMed
    Score: 0.018
  25. Rhabdomyosarcoma treatment and outcome at a multidisciplinary pediatric cancer center in Lebanon. Pediatr Hematol Oncol. 2012 May; 29(4):322-34.
    View in: PubMed
    Score: 0.015
  26. Inherited thrombophilia in childhood arterial stroke: data from Lebanon. Pediatr Neurol. 2011 Sep; 45(3):155-8.
    View in: PubMed
    Score: 0.015
  27. Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models. Pediatr Hematol Oncol. 2011 Nov; 28(8):676-81.
    View in: PubMed
    Score: 0.015
  28. Abdominal complications of chemotherapy in pediatric malignancies: imaging findings. Clin Imaging. 2009 Jul-Aug; 33(4):253-60.
    View in: PubMed
    Score: 0.013
  29. First-line therapy of generalized infantile myofibromatosis with low-dose vinblastine and methotrexate. Pediatr Blood Cancer. 2009 Feb; 52(2):308.
    View in: PubMed
    Score: 0.012
  30. Familial infantile pyknocytosis in association with pulmonary hypertension. Pediatr Blood Cancer. 2008 Aug; 51(2):290-2.
    View in: PubMed
    Score: 0.012
  31. Autoimmune neutropenia of childhood. Crit Rev Oncol Hematol. 1987; 7(1):37-51.
    View in: PubMed
    Score: 0.011
  32. Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. J Pediatr. 1985 Oct; 107(4):537-41.
    View in: PubMed
    Score: 0.010
  33. Interleukin 8 in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication. Arch Dis Child. 2000 Feb; 82(2):165-8.
    View in: PubMed
    Score: 0.007
  34. Costs, charges, and reimbursements for persons with sickle cell disease. J Pediatr Hematol Oncol. 1999 Sep-Oct; 21(5):389-96.
    View in: PubMed
    Score: 0.006
  35. Dynamics of interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics. Infection. 1999 May-Jun; 27(3):173-6.
    View in: PubMed
    Score: 0.006
  36. Survival with combined modality therapy after intracerebral recurrence of pleuropulmonary blastoma. Med Pediatr Oncol. 1998 Jan; 30(1):63-6.
    View in: PubMed
    Score: 0.006
  37. Successful treatment of relapsed infant acute lymphoblastic leukemia with intensive antimetabolite-based chemotherapy. Med Pediatr Oncol. 1997 Oct; 29(4):256-9.
    View in: PubMed
    Score: 0.006
  38. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood. 1997 Mar 01; 89(5):1533-42.
    View in: PubMed
    Score: 0.005
  39. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995 Jul 27; 333(4):206-13.
    View in: PubMed
    Score: 0.005
  40. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun; 126(6):896-9.
    View in: PubMed
    Score: 0.005
  41. Opsoclonus-myoclonus and recurrent neuroblastoma. J Pediatr. 1995 May; 126(5 Pt 1):847-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.